{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-160421","form_type":"8-K","ticker":"LYRA","cik":"0001327273","company_name":"Lyra Therapeutics, Inc.","filed_at":"2026-04-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.140990+00:00","generated_at":"2026-05-15T05:27:59.639554+00:00","sec_items":["1.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"confidence":"high","headline":"Lyra Therapeutics terminates Waltham sublease; pays $2.1M termination fee","bullets":["Termination of sublease for 23,704 sq ft at 880 Winter Street, Waltham, MA, effective March 31, 2026.","Company pays $2,100,000 termination payment; rent obligations ceased January 31, 2026.","Upon surrender and payment, RVAC Medicines will release $600,501 letter of credit security deposit.","Sublease originally dated December 21, 2023; premises must be surrendered by May 31, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-160421","json":"https://secwatch.observer/filing/0001193125-26-160421.json","markdown":"https://secwatch.observer/filing/0001193125-26-160421.md","text":"https://secwatch.observer/filing/0001193125-26-160421.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1327273/000119312526160421/0001193125-26-160421-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1327273/000119312526160421/d121976d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T05:27:59.639554+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}